Schrödinger is revolutionizing drug development with its AI-powered molecular modeling and simulation platform, enabling researchers to predict molecular interactions, optimize lead compounds, and accelerate pharmaceutical innovation. The platform's machine learning algorithms integrate quantum mechanics, cheminformatics, and structural biology to deliver accurate predictions for drug discovery. Schrödinger collaborates with leading pharma companies, biotech firms, and academic institutions, supporting projects across therapeutic areas. With robust data security, scalable cloud infrastructure, and continuous updates, Schrödinger is advancing the science of molecular medicine. SEO keywords: "Schrödinger AI drug discovery," "AI molecular modeling platform," "quantum simulation drug development," "AI pharmaceutical innovation," "Schrödinger molecular medicine."